醫療事務的評價 (EU5個國家) :多發性硬化症
Medical Affairs Reputations (EU5): Multiple Sclerosis
|醫療事務的評價 (EU5個國家) :多發性硬化症 Medical Affairs Reputations (EU5): Multiple Sclerosis|
|出版日期: 2015年07月01日||內容資訊: 英文||
本報告以對應多發性硬化症患者的神經科醫生為對象，進行9個多發性硬化症 (MS) 治療藥中至少涉及1個的醫療事務 (MA) 相關意見調查，醫生想得到來自MA團隊幫助的重要問題，醫生對於MA團隊的整體實際成果滿足程度，以及如何改善實際成果，未滿足醫生需求的是MA團隊所提供服務的哪個方面，及醫生喜歡與MA專家交流的方法等相關資料彙整。
Compare how well pharma Medical Affairs teams perform and find out which ones physicians rate, in our exclusive report on the Multiple Sclerosis sector. See how well your team stacks up against the competition and where work is still needed.
As well as this timely report weighing up the performance of the European Medical Affairs teams, you can also get an equivalent report for the US. If you buy both reports, we'll save you time and effort by giving you an additional free report that clearly sets out the differences in findings between both regions.
We asked neurologists who see patients with Multiple Sclerosis for their opinions on the Medical Affairs professionals they had dealt with in relation to at least one of the 9 MS drugs considered. Their frank responses reveal key areas of concern for you and what you should focus on to improve neurologists' satisfaction. Areas where the teams are giving a solid performance are also highlighted.